Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

New Version of Concentriq Dx Enables 100% Digital Diagnosis

Proscia
By Author Proscia | October 12, 2022

Proscia, a provider of digital and computational pathology solutions, has introduced the next version of its Concentriq Dx platform. The upgraded version of its Concentriq Dx platform is for primary diagnostic workflows, which is CE marked under IVDR*.

Our website uses cookies. By using this site, you agree to its use of cookies.